Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
AI-assisted disclosure: This article is AI-assisted drafting, human reviewed every published sentence was reviewed by a licensed patient advocate before going live
This medicine may cause the following problems:Increased risk of thyroid tumorPancreatitis (swelling of the pancreas)Gallbladder problems, including cholelithiasis, cholecystitisLow blood sugar (when used with other diabetes medicine)Dehydration, which can lead to kidney problemsSevere stomach or bowel problemsEye or vision problems, including diabetic retinopathyIncreased heart rateIncreased risk for depression or thoughts of suicideIncreased risk of food or liquid getting into the lungs during surgery or other procedures Tell your doctor if you are pregnant or planning to become pregnant
Some people lose 30 percent
Headache Infrequent, and when present, usually mild and limited to the initial adjustment period
Also in China, Eli Lilly recently filed for approval of a new GLP-1 treatment and completed a Phase 1 trial for a related medication
La semaglutida es un anlogo del pptido 1 similar al glucagn (GLP-1), que demostr ser altamente eficaz y potente en el control de la glucosa en sangre
US$ 22.17
US$ 28.26
US$ 20.36
US$ 28.45
